Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma

PLoS Medicine

Volumn 7, Issue 7, 2010, Pages

  Lockwood, William W ^a   Chari, Raj ^a   Coe, Bradley P ^a   Thu, Kelsie L ^a   Garnis, Cathie ^a   Malloff, Chad A ^a   Campbell, Jennifer ^a   Williams, Ariane C ^a   Hwang, Dorothy ^a   Zhu, Chang Qi ^b   Buys, Timon P H ^a   Yee, John ^c   English, John C ^c   MacAulay, Calum ^a   Tsao, Ming Sound ^b   Gazdar, Adi F ^d   Minna, John D ^d   Lam, Stephen ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRF2 PROTEIN; DNA DIRECTED RNA POLYMERASE III; SMALL NUCLEAR RNA; TUMOR MARKER; UNCLASSIFIED DRUG; BRF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR IIIB;

ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SPECIFICITY; CHROMOSOME 8P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; ONCOGENE; RNA PROCESSING; SMOKING; ADENOCARCINOMA; ANTIBODY SPECIFICITY; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; LUNG TUMOR; MALE; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; SYSTEM ANALYSIS; TUMOR CELL CULTURE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL LINEAGE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LUNG NEOPLASMS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; ORGAN SPECIFICITY; SYSTEMS INTEGRATION; TRANSCRIPTION FACTOR TFIIIB; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77955034636     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000315     Document Type: Article

References (63)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
3. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
4. Travis WD (2002) Pathology of lung cancer. Clin Chest Med 23: 65-81, viii.
5. Kim HS, Park K, Jun HJ, Yi SY, Lee J, et al. (2009) Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras. Oncology 76: 239-246.
6. Scagliotti G, Hanna N, Fossella F, Sugarman K, Blatter J, et al. (2009) The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. Oncologist 14: 253-263.
7. Garraway LA, Sellers WR (2006) Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6: 593-602.
8. Giangreco A, Groot KR, Janes SM (2007) Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 175: 547-553.
9. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, et al. (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15: 3249-3262.
10. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas M, et al. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4: 111-120.
11. Meuwissen R, Linn SC, van der Valk M, Mooi WJ, Berns A (2001) Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20: 6551-6558.
12. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116.
13. Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, et al. (2005) "Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol 70: 25-34.
14. Albertson DG (2006) Gene amplification in cancer. Trends Genet 22: 447-455.
15. Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, et al. (2008) DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27: 4615-4624.
16. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, et al. (2007) Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A 104: 16663-16668.
17. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, et al. (2005) Highresolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A 102: 9625-9630.
18. Garnis C, Davies JJ, Buys TP, Tsao MS, MacAulay C, et al. (2005) Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene 24: 4806-4812.
19. Lockwood WW, Coe BP, Williams AC, MacAulay C, Lam WL (2007) Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer 120: 436-443.
20. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567.
21. Coe BP, Lockwood WW, Girard L, Chari R, Macaulay C, et al. (2006) Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer 94: 1927-1935.
22. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, et al. (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303.
23. Watson SK, deLeeuw RJ, Horsman DE, Squire JA, Lam WL (2007) Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 120: 795-805.
24. Khojasteh M, Lam WL, Ward RK, MacAulay C (2005) A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6: 274.
25. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL (2004) SeeGH-a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5: 13.
26. Chi B, deLeeuw RJ, Coe BP, Ng RT, MacAulay C, et al. (2008) MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data. BMC Bioinformatics 9: 243.
27. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B (2004) Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20: 3636-3637.
28. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
29. Chari R, Lonergan KM, Ng RT, MacAulay C, Lam WL, et al. (2007) Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics 8: 297.
30. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034.
31. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, et al. (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66: 2116-2128.
32. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
33. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
34. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA (2001) Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 125: 87-99.
35. Sy SM, Wong N, Lee TW, Tse G, Mok TS, et al. (2004) Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer 40: 1082-1094.
36. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
37. Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, et al. (2005) Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65: 5561-5570.
38. Schramm L, Pendergrast PS, Sun Y, Hernandez N (2000) Different human TFIIIB activities direct RNA polymerase III transcription from TATAcontaining and TATA-less promoters. Genes Dev 14: 2650-2663.
39. Cabart P, Murphy S (2001) BRFU, a TFIIB-like factor, is directly recruited to the TATA-box of polymerase III small nuclear RNA gene promoters through its interaction with TATA-binding protein. J Biol Chem 276: 43056-43064.
40. White RJ (2004) RNA polymerase III transcription and cancer. Oncogene 23: 3208-3216.
41. White RJ (2005) RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 6: 69-78.
42. Goodfellow SJ, White RJ (2007) Regulation of RNA polymerase III transcription during mammalian cell growth. Cell Cycle 6: 2323-2326.
43. Woiwode A, Johnson SA, Zhong S, Zhang C, Roeder RG, et al. (2008) PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol 28: 4204-4214.
44. Felton-Edkins ZA, Kenneth NS, Brown TR, Daly NL, Gomez-Roman N, et al. (2003) Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2: 181-184.
45. Gomez-Roman N, Felton-Edkins ZA, Kenneth NS, Goodfellow SJ, Athineos D, et al. (2006) Activation by c-Myc of transcription by RNA polymerases I, II and III. Biochem Soc Symp. pp 141-154.
46. Marshall L, Kenneth NS, White RJ (2008) Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell 133: 78-89.
47. Johnson SA, Dubeau L, Johnson DL (2008) Enhanced RNA polymerase IIIdependent transcription is required for oncogenic transformation. J Biol Chem 283: 19184-19191.
48. Schramm L, Hernandez N (2002) Recruitment of RNA polymerase III to its target promoters. Genes Dev 16: 2593-2620.
49. Saxena A, Ma B, Schramm L, Hernandez N (2005) Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the Cterminal domain in RNA polymerase III transcription. Mol Cell Biol 25: 9406-9418.
50. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A (2007) The expanding RNA polymerase III transcriptome. Trends Genet 23: 614-622.
51. Cabarcas S, Jacob J, Veras I, Schramm L (2008) Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells. BMC Mol Biol 9: 74.
52. Wistuba, II, Gazdar AF (2006) Lung cancer preneoplasia. Annu Rev Pathol 1: 331-348.
53. Sato M, Shames DS, Gazdar AF, Minna JD (2007) A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2: 327-343.
54. Rew DA (2003) Small RNAs: a new class of genome regulators and their significance. Eur J Surg Oncol 29: 764-765.
55. Butcher SE, Brow DA (2005) Towards understanding the catalytic core structure of the spliceosome. Biochem Soc Trans 33: 447-449.
56. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17: 419-437.
57. Henry RW, Mittal V, Ma B, Kobayashi R, Hernandez N (1998) SNAP19 mediates the assembly of a functional core promoter complex (SNAPc) shared by RNA polymerases II and III. Genes Dev 12: 2664-2672.
58. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, et al. (2008) Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27: 3635-3640.
59. Tanaka H, Yanagisawa K, Shinjo K, Taguchi A, Maeno K, et al. (2007) Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 67: 6007-6011.
60. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
61. Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, et al. (2009) TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 217: 65-72.
62. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380.
63. Bass AJ, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.